Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats.
about
The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned ratsFos expression in response to dopamine D3-preferring phenylpiperazine drugs given with and without cocaineUsing prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in ratsDopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ anCombined treatment with acupuncture reduces effective dose and alleviates adverse effect of L-dopa by normalizing Parkinson's disease-induced neurochemical imbalance.N-(3-fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as selective dopamine D3 receptor ligands: critical role of the carboxamide linker for D3 receptor selectivity.Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds.D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesiaReduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on L-dopa dependent animal involuntary movements in rats.Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions.Molecular imaging of levodopa-induced dyskinesias.Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental L-DOPA-induced dyskinesia.Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D3 receptor ligands.Effect of cyclosporin A on the uptake of D3-selective PET radiotracers in rat brain.Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson's disease: role of NMDA vs. 5-HT1A receptorsEngineering a GPCR-ligand pair that simulates the activation of D(2L) by Dopamine.The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice.Sustained increase of PKA activity in the postcommissural putamen of dyskinetic monkeys.Selective inhibition of M5 muscarinic acetylcholine receptors attenuates cocaine self-administration in rats.Selectivity of probes for PET imaging of dopamine D3 receptors.
P2860
Q28482094-B54A778F-FF14-4996-A7A2-91B072CC49B4Q30424415-2922A1C6-CFC9-431D-A8F1-97EA88FD0131Q30480298-C7BDDF9B-A68C-46EF-936A-36B68833DAADQ30581703-979FAF96-0CD0-460F-A044-A0972DCCA831Q33697312-12F3C5A4-3273-4E5D-B7D9-10086CD03FFDQ34267133-54B5283B-812B-41E8-B58D-58E106825999Q34269201-BB6754A0-B671-4EF7-AE9C-69451E0D7394Q35001217-5F11B785-7021-4C3F-A294-EC9CEA97866EQ36479708-2E12750C-9F51-43FC-A6A1-485DC212B97DQ36521275-98E4E928-D9B4-4DF6-A12C-96CAC39CE740Q37252065-FE2DB4AB-CFDB-4E83-9D9A-D8DAFB563F2EQ37286549-ED3D37A7-FF1C-40A7-9E19-46B5C83C999AQ38207680-FED3087D-9EF7-45CF-8D7C-22D4E121C6D1Q38355582-44E9DFBF-3298-4151-B24E-7FC7BFC11003Q38479031-544EF780-1B60-4FE6-8D5A-7BEF4EC73B46Q38931640-8B962A6E-3C80-4ED3-94AA-1B5A43ACFC00Q41629621-56D0638B-E609-4FBB-A42B-FDFFE3F9D4EAQ42035376-0ECC2918-50ED-4331-83C9-5FE65918FB36Q42121362-4C5BB0EE-CA36-4C77-88E0-37744A15838EQ42185342-7A51C55F-AB97-4AF4-A6EA-72D7167C21CAQ42647545-69CF2166-75A6-4A9B-BBEC-0E4D5CEB140BQ44639804-01651935-81E8-48B8-91F2-1935B26E1AACQ48167663-8F42130B-BEA5-4C4E-82CB-E564783B598CQ52316241-A845E74B-7A32-4706-92FD-A7455781014D
P2860
Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Evaluation of D2 and D3 dopami ...... involuntary movements in rats.
@ast
Evaluation of D2 and D3 dopami ...... involuntary movements in rats.
@en
type
label
Evaluation of D2 and D3 dopami ...... involuntary movements in rats.
@ast
Evaluation of D2 and D3 dopami ...... involuntary movements in rats.
@en
prefLabel
Evaluation of D2 and D3 dopami ...... involuntary movements in rats.
@ast
Evaluation of D2 and D3 dopami ...... involuntary movements in rats.
@en
P2093
P2860
P1433
P1476
Evaluation of D2 and D3 dopami ...... involuntary movements in rats
@en
P2093
Lindsay R Riddle
Rakesh Kumar
Robert H Mach
Robert R Luedtke
Suwanna Vangveravong
Suzy A Griffin
Wenhua Chu
P2860
P304
P356
10.1016/J.NEUROPHARM.2009.01.019
P577
2009-02-05T00:00:00Z